ArticleThe Indian journal of medical research2026
Tuberculosis prophylaxis and long-term safety in adalimumab biosimilar therapy: The need for strengthened vigilance.
Chaitra C S et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it